Clinical Trials Logo

Metastases to Brain clinical trials

View clinical trials related to Metastases to Brain.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05485038 Recruiting - Glioma, Malignant Clinical Trials

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas

GAMMA
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

NCT ID: NCT05475522 Recruiting - Metastases to Brain Clinical Trials

Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases

SONOFLUO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine whether intraoperative ultrasound guided resection of gliomas with contrast enhancement in magnetic resonance imaging and brain metastases can achieve as high rate of gross total resection as fluorescence-guided surgery with 5-aminolevulinic acid

NCT ID: NCT05474573 Recruiting - Glioma, Malignant Clinical Trials

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

CONFLUENSE
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine whether combined use of intraoperative fluorescence with 5-aminolevulinic acid (5-ALA) and sonography can achieve higher rate of gross total resection of contrast-enhancing gliomas and brain metastases compared to intraoperative fluorescence with 5-ALA alone.